A comprehensive view of Clinical Trials. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Efforts are ongoing to rescue gene therapy for rare disease ADA-SCiD; researchers at UCL and UCLA are developing the non-FDA approved simoladagene autotemcel therapy, supported by nonprofits
Published: July 26, 2024 by MarketLine
Johnson & Johnson offers $250K grant to promote diversity in clinical trials; initiative focuses on immune-mediated diseases and provides access to JLABS network and mentorship opportunities
Published: July 26, 2024 by Industry Intelligence Inc.
Bristol-Myers Squibb advances healthcare with CAR T therapy trials; company supports patient accessibility with travel aid for lupus study participants, emphasizing commitment to equitable treatment
Published: July 26, 2024 by Industry Intelligence Inc.
Eisai and Biogen disappointed by EMA's negative opinion on lecanemab for early Alzheimer's; the humanized anti-amyloid-beta monoclonal antibody was under review for mild cognitive impairment
Published: July 26, 2024 by Biogen Inc.
Merck receives positive EU CHMP opinion for KEYTRUDA and Padcev for first-line treatment of unresectable or metastatic urothelial carcinoma; based on Phase 3 KEYNOTE-A39 trial results
Published: July 26, 2024 by Merck & Co. Inc.

Ask us about our Bioeconomy market view

Trending Chart

Interactive chart with headline count